ANIEMEA-P-GB-202600051 | January 2026
Authors:
Imogen Watson, RD
Publish Date:
August 2025 | 6 min
Abstract:
This article emphasises the importance of early identification and management through a structured four-step approach: screening, assessment, treatment, and monitoring. It highlights the role of healthcare professionals in recognising risk factors, addressing gastrointestinal (GI) intolerance, and optimising nutritional interventions. Appropriate use of oral nutritional supplements, particularly peptide-based formulas for patients with malabsorption and GI dysfunction, can improve clinical outcomes, reduce complications, and lower healthcare costs.
Once you have read this article, please remember to complete your self-reflective notes to contribute towards your continuing professional development. You will then be able to access your Certificate of Completion.
LEARNING OBJECTIVES
Understand the prevalence, impact, and economic burden of malnutrition in the UK and its implications for patient outcomes
Learn the four-step framework for managing malnutrition, including screening tools, assessment strategies, and monitoring protocols
Recognise the importance of addressing GI intolerance and selecting appropriate nutritional interventions, such as peptide-based ONS, to improve tolerance, compliance, and clinical effectiveness
AUTHOR(S) BIO
IMOGEN WATSON, RD
Head of Medical and Scientific Affairs, Abbott
Imogen is Head of Medical and Scientific Affairs at Abbott. Having qualified as a registered dietitian in 2000, Imogen spent 10 years in the NHS where she specialised in nutritional support.
In 2010, Imogen moved to work in the Medical Nutrition Industry, and currently works at Abbott, a healthcare company. In this role she provides scientific support and promotes evidence-based nutrition.
She is a member of the BDA, and is also a member of several of the specialist groups of the BDA. Imogen was the Secretary for the British Association for Parenteral and Enteral Nutrition (BAPEN) Education and Training Committee (2013-2017) and treasurer for the BDA Parenteral and Enteral Nutrition Group (2016-2021). She is currently treasurer for the BDA Industry Specialist Group and has been since 2023.
